cromolyn sodium has been researched along with Hematologic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikezawa, Z; Inokuma, S; Onoda, M | 1 |
| Worobec, AS | 1 |
2 review(s) available for cromolyn sodium and Hematologic Diseases
| Article | Year |
|---|---|
[Adverse effects of chemical mediator release inhibitors].
Topics: Administration, Inhalation; Administration, Oral; Anti-Allergic Agents; Asthma; Contraindications; Cromolyn Sodium; Cystitis; Dermatitis, Atopic; Digestive System Diseases; Drug Eruptions; Hematologic Diseases; Humans; Kidney Diseases; ortho-Aminobenzoates | 2007 |
Treatment of systemic mast cell disorders.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Antineoplastic Agents; Aspirin; Cholinergic Antagonists; Clinical Trials as Topic; Combined Modality Therapy; Contraindications; Cromolyn Sodium; Diphosphonates; Flushing; Follow-Up Studies; Hematologic Diseases; Histamine Antagonists; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Leukemia, Mast-Cell; Mast-Cell Sarcoma; Mastocytosis; Osteoporosis; Photochemotherapy; Proto-Oncogene Proteins c-kit; Recombinant Proteins; Skin Neoplasms; Treatment Outcome | 2000 |